TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
72.26
+1.13 (1.59%)
Jul 24, 2026, 4:00 PM EDT - Market closed
TransMedics Group Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 461.74 | 488.37 | 336.65 | 394.81 | 201.18 | 25.58 |
Short-Term Investments | - | - | - | - | - | 66.87 |
Cash & Short-Term Investments | 461.74 | 488.37 | 336.65 | 394.81 | 201.18 | 92.45 |
Cash Growth | 48.88% | 45.07% | -14.73% | 96.25% | 117.61% | -26.42% |
Accounts Receivable | 90.73 | 84.28 | 97.72 | 63.58 | 27.61 | 5.93 |
Inventory | 49.89 | 48.88 | 46.55 | 44.24 | 20.61 | 14.86 |
Other Current Assets | 16.92 | 16.25 | 16.29 | 8.03 | 2.9 | 5.46 |
Total Current Assets | 619.28 | 637.78 | 497.22 | 510.65 | 252.29 | 118.71 |
Net Property, Plant & Equipment | 700.97 | 332.81 | 292.45 | 180.49 | 24.35 | 15.69 |
Other Intangible Assets | - | 1.95 | 2.15 | 2.35 | - | - |
Goodwill | 11.55 | 11.55 | 11.55 | 11.99 | - | - |
Other Long-Term Assets | 103.02 | 84.28 | 0.71 | 0.56 | 0.5 | 0.5 |
Total Assets | 1,435 | 1,068 | 804.08 | 706.05 | 277.15 | 134.89 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 11.15 | 10.35 | 10.29 | 12.72 | 3.34 | 6.65 |
Accrued Expenses | 59.32 | 62.74 | 45.15 | 38.22 | 18.64 | 16.34 |
Current Portion of Long-Term Debt | 15 | 10 | - | - | - | - |
Current Portion of Leases | 3.51 | 3.31 | 2.73 | 2.04 | 1.44 | - |
Unearned Revenue | 2.95 | 2.91 | 1.74 | 1.96 | 0.24 | 0.25 |
Total Current Liabilities | 91.92 | 89.31 | 59.91 | 54.93 | 23.66 | 23.24 |
Long-Term Debt | 498.2 | 502.39 | 509.31 | 506.2 | 58.7 | 35.2 |
Long-Term Leases | 346.71 | 3.58 | 6.25 | 7.71 | 7.42 | 8.6 |
Other Long-Term Liabilities | 3.99 | - | - | - | - | - |
Total Long-Term Liabilities | 848.89 | 505.97 | 515.56 | 513.91 | 66.11 | 43.8 |
Total Liabilities | 940.81 | 595.27 | 575.47 | 568.85 | 89.77 | 67.04 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 764.64 | 750.93 | 697.21 | 641.11 | 666.28 | 510.49 |
Accumulated Other Comprehensive Income | 0 | 0.12 | -0.36 | -0.2 | -0.23 | -0.19 |
Retained Earnings | -270.64 | -277.95 | -468.24 | -503.71 | -478.68 | -442.45 |
Shareholders' Equity | 494.01 | 473.1 | 228.6 | 137.2 | 187.38 | 67.85 |
Total Liabilities & Equity | 1,435 | 1,068 | 804.08 | 706.05 | 277.15 | 134.89 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 863.42 | 519.28 | 518.29 | 515.95 | 67.56 | 43.8 |
Net Cash (Debt) | -401.68 | -30.91 | -181.64 | -121.13 | 133.63 | 48.65 |
Net Cash Growth | - | - | - | - | 174.66% | -46.53% |
Net Cash Per Share | -10.14 | -0.76 | -5.16 | -3.73 | 4.52 | 1.76 |
Book Value | 494.01 | 473.1 | 228.6 | 137.2 | 187.38 | 67.85 |
Book Value Per Share | 12.47 | 11.67 | 6.49 | 4.22 | 6.34 | 2.46 |
Tangible Book Value | 482.46 | 459.6 | 214.9 | 122.86 | 187.38 | 67.85 |
Tangible Book Value Per Share | 12.18 | 11.34 | 6.10 | 3.78 | 6.34 | 2.46 |